- Home
- SOBR vs INM Comparison
SOBR vs INM Comparison
Compare SOBR & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOBR
- INM
- Stock Information
- Founded
- SOBR 2004
- INM 1981
- Country
- SOBR United States
- INM Canada
- Employees
- SOBR N/A
- INM N/A
- Industry
- SOBR Newspapers/Magazines
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SOBR Consumer Discretionary
- INM Health Care
- Exchange
- SOBR Nasdaq
- INM Nasdaq
- Market Cap
- SOBR 5.2M
- INM 5.0M
- IPO Year
- SOBR N/A
- INM N/A
- Fundamental
- Price
- SOBR $3.42
- INM $1.88
- Analyst Decision
- SOBR
- INM
- Analyst Count
- SOBR 0
- INM 0
- Target Price
- SOBR N/A
- INM N/A
- AVG Volume (30 Days)
- SOBR 86.8K
- INM 107.8K
- Earning Date
- SOBR 11-13-2025
- INM 11-13-2025
- Dividend Yield
- SOBR N/A
- INM N/A
- EPS Growth
- SOBR N/A
- INM N/A
- EPS
- SOBR N/A
- INM N/A
- Revenue
- SOBR $301,400.00
- INM $4,942,633.00
- Revenue This Year
- SOBR N/A
- INM N/A
- Revenue Next Year
- SOBR N/A
- INM N/A
- P/E Ratio
- SOBR N/A
- INM N/A
- Revenue Growth
- SOBR 73.21
- INM 7.50
- 52 Week Low
- SOBR $2.41
- INM $1.72
- 52 Week High
- SOBR $69.39
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- SOBR 49.57
- INM 32.92
- Support Level
- SOBR $3.10
- INM $2.04
- Resistance Level
- SOBR $3.47
- INM $2.14
- Average True Range (ATR)
- SOBR 0.30
- INM 0.12
- MACD
- SOBR 0.00
- INM -0.02
- Stochastic Oscillator
- SOBR 45.71
- INM 3.70
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.